Video Series: Dr. Dotters-Katz weighs in on COVID-19 in pregnancy
Dr. Sarah Dotters-Katz is a maternal-fetal medicine specialist and obstetrician and gynecologist at Duke Health in Durham, N.C. One of her research interests is clinical infectious diseases and how they impact pregnancy.
Dr. Sarah Dotters-Katz is a maternal-fetal medicine specialist and obstetrician and gynecologist at Duke Health in Durham, N.C. One of her research interests is clinical infectious diseases and how they impact pregnancy.
In this video, Dr. Dotters-Katz discusses her perspective on COVID-19’s impact on pregnant patients with Senior Editor Angie DeRosa. Dotters-Katz also includes what she is seeing in her area of the United States. She has been very active in spreading her knowledge. She wrote a commentary in the April issue of Contemporary OB/GYN with Dr. Brenna Hughes, entitled, “COVID-19: The pathogen that will define the decade.”
She and Dr. Hughes also did a review recently for the American Journal of Perinatology, “Considerations for obstetric care during the COVID-19 pandemic,” in which they discussed the key points that COVID-19 severity in pregnancy is unclear and social distancing is the best protective mechanism. There is no clear evidence that vertical transmission exists. If a mother is positive, then mother/ baby separation avoids transmission. That article abstract can be found here.
Rising endometriosis rates linked to increased pregnancy complications
May 19th 2024A new study presented at the 2024 ACOG meeting reveals a significant rise in endometriosis among pregnant women over the past 20 years, linking the condition to increased obstetric and neonatal complications.
Read More
S4E1: New RNA platform can predict pregnancy complications
February 11th 2022In this episode of Pap Talk, Contemporary OB/GYN® sat down with Maneesh Jain, CEO of Mirvie, and Michal Elovitz, MD, chief medical advisor at Mirvie, a new RNA platform that is able to predict pregnancy complications by revealing the biology of each pregnancy. They discussed recently published data regarding the platform's ability to predict preeclampsia and preterm birth.
Listen
Study reveals critical gaps in care for PCOS patients
May 17th 2024A new study presented at the 2024 ACOG Annual Clinical and Scientific Meeting highlighted significant gaps in polycystic ovary syndrome (PCOS) care, revealing widespread patient dissatisfaction and the urgent need for improved provider education and comprehensive treatment approaches.
Read More
Contemporary OB/GYN Senior Editor Angie DeRosa gets insight on the current state of COVID-19 from Christina Han, MD, division director of maternal-fetal medicine at the University of California, Los Angeles, and member of its COVID-19 task force. Han is an active member of the Society for Maternal-Fetal Medicine and discusses the issues on behalf of SMFM.
Listen
PCOS and irregular cycles tied to cardiometabolic risks
May 15th 2024A comprehensive analysis reveals strong associations between polycystic ovary syndrome, irregular menstrual cycles, and increased risks of cardiometabolic conditions, underscoring the importance of proactive screening and intervention strategies.
Read More
Prenatal cannabis and nicotine use linked to adverse pregnancy outcomes
May 14th 2024A recent study highlights the heightened risks of maternal and neonatal morbidity and mortality associated with combined cannabis and nicotine use during pregnancy, urging further investigation into their impact on short- and long-term outcomes.
Read More
